ticlopidine has been researched along with Lymphocytopenia in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stefanini, L | 1 |
| Paul, DS | 1 |
| Robledo, RF | 1 |
| Chan, ER | 1 |
| Getz, TM | 1 |
| Campbell, RA | 1 |
| Kechele, DO | 1 |
| Casari, C | 1 |
| Piatt, R | 1 |
| Caron, KM | 1 |
| Mackman, N | 1 |
| Weyrich, AS | 1 |
| Parrott, MC | 1 |
| Boulaftali, Y | 1 |
| Adams, MD | 1 |
| Peters, LL | 1 |
| Bergmeier, W | 1 |
1 other study available for ticlopidine and Lymphocytopenia
| Article | Year |
|---|---|
RASA3 is a critical inhibitor of RAP1-dependent platelet activation.
Topics: Animals; Cellular Senescence; Clopidogrel; GTPase-Activating Proteins; Guanine Nucleotide Exchange F | 2015 |